Dermata Stock Valuation

DRMA -  USA Stock  

USD 1.68  0.17  11.26%

Do you wonder what the value of Dermata Therapeutics is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Dermata Therapeutics, is its stock price multiplied by the total number of shares outstanding, calculating Dermata Therapeutics' enterprise value requires a different approach. It uses Dermata Therapeutics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
The current year Tangible Asset Value is expected to grow to about 849.2 K, whereas Free Cash Flow is forecasted to decline to (3.9 M).
Dermata Therapeutics shows a prevailing Real Value of $4.12 per share. The current price of the firm is $1.68. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model computes the value of Dermata Therapeutics from reviewing the firm fundamentals such as Number of Shares Shorted of 50.12 K, price to book of 1.01 X, and Shares Owned by Insiders of 46.17 % as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.

Dermata Valuation 

 
Refresh
Dermata Therapeutics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Dermata Therapeutics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
1.68
19th of January 2022
Share
Please note that Dermata Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Dermata Therapeutics is based on 3 months time horizon. Increasing Dermata Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Dermata Therapeutics is useful when determining the fair value of the Dermata stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Dermata Therapeutics. Since Dermata Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dermata Stock. However, Dermata Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
4.12
Real Value
12.92
Upside
Estimating the potential upside or downside of Dermata Therapeutics helps investors to forecast how Dermata stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dermata Therapeutics more accurately as focusing exclusively on Dermata Therapeutics' fundamentals will not take into account other important factors:
Earnings
Estimates (1)
LowProjected EPSHigh
-2.39-2.39-2.39
Details
Hype
Prediction
LowEstimated ValueHigh
0.102.0710.87
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.0011.5014.00
Details

Dermata Therapeutics Total Value Analysis

Dermata Therapeutics is currently expected to have valuation of 306.03 K with market capitalization of 12.58 M, debt of , and cash on hands of 12.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Dermata Therapeutics fundamentals before making equity appraisal based on enterprise value of the company

Dermata Therapeutics Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Dermata suggests not a very effective usage of assets in January.

Dermata Therapeutics Ownership Allocation (%)

The market capitalization of Dermata Therapeutics is $12.58 Million. Dermata Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 Ownership % 
      Values 

Dermata Therapeutics Profitability Analysis

Net Loss for the year was (8.31 M).

About Dermata Therapeutics Valuation

The equity valuation mechanism determines the current worth of Dermata Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Dermata Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Dermata Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Dermata Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Dermata Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dermata Therapeutics. We calculate exposure to Dermata Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dermata Therapeutics's related companies.
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company was founded in 2014 and is headquartered in San Diego, California. Dermata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

Dermata Therapeutics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Dermata Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio10.55
Enterprise Value To Ebitda-0.05

Dermata Therapeutics Current Valuation Indicators

Valuation refers to the process of determining the present value of Dermata Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Dermata we look at many different elements of the entity such as Dermata's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Dermata Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Dermata Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Dermata Therapeutics' worth.
Continue to Investing Opportunities. Note that the Dermata Therapeutics information on this page should be used as a complementary analysis to other Dermata Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Dermata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Dermata Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.